159 related articles for article (PubMed ID: 6103813)
1. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Eur J Pharmacol; 1980 May; 63(2-3):135-44. PubMed ID: 6103813
[TBL] [Abstract][Full Text] [Related]
2. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
Clow A; Jenner P; Theodorou A; Marsden CD
Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
[No Abstract] [Full Text] [Related]
4. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Psychopharmacology (Berl); 1980; 69(3):227-33. PubMed ID: 6774362
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic drugs and the dopamine hypothesis.
Clow A; Jenner P; Theodorou A; Marsden CD
Lancet; 1979 Apr; 1(8122):934. PubMed ID: 86713
[No Abstract] [Full Text] [Related]
6. Changes in dopamine-mediated behaviour during one year's neuroleptic administration.
Clow A; Jenner P; Marsden CD
Eur J Pharmacol; 1979 Aug; 57(4):365-75. PubMed ID: 39769
[TBL] [Abstract][Full Text] [Related]
7. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
[TBL] [Abstract][Full Text] [Related]
8. Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 months.
Murugaiah K; Theodorou A; Jenner P; Marsden CD
Neuroscience; 1983 Nov; 10(3):811-9. PubMed ID: 6685826
[TBL] [Abstract][Full Text] [Related]
9. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
[TBL] [Abstract][Full Text] [Related]
10. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
[TBL] [Abstract][Full Text] [Related]
11. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
Clow A; Theodorou A; Jenner P; Marsden CD
Adv Biochem Psychopharmacol; 1980; 24():335-40. PubMed ID: 7190762
[No Abstract] [Full Text] [Related]
12. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
13. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
15. During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
Dyer RG; Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
Life Sci; 1981 Jan; 28(2):167-74. PubMed ID: 6114373
[No Abstract] [Full Text] [Related]
16. Regional effects of neuroleptics on dopamine metabolism and dopamine-sensitive adenylate cyclase activity.
Scatton B; Bischoff S; Dedek J; Korf J
Eur J Pharmacol; 1977 Aug; 44(4):287-92. PubMed ID: 19266
[TBL] [Abstract][Full Text] [Related]
17. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
18. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.
Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
Psychopharmacology (Berl); 1985; 86(1-2):228-32. PubMed ID: 3927361
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
Hong M; Jenner P; Marsden CD
Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
[TBL] [Abstract][Full Text] [Related]
20. Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.
McMillen BA
J Neural Transm; 1985; 64(1):1-12. PubMed ID: 2866230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]